Zaxilin Pharma Private Limited
About Zaxilin Pharma Private Limited
Data last updated:
Zaxilin Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the manufacturing segment of the food and beverages sector. It was incorporated on 25 October 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24304TG2017PTC120243. Its GSTIN is 36AABCZ1390A1ZM (Telangana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rama Devi Kolasani and Kolasani Srinivasa Rao.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at H.No.1 – 5 – 209 New Maruthi Nagar Kothapet, Hyderabad, Telangana, India – 500035.
As per the financials filed for FY 2023, the company reported a revenue of ₹8.34 Lakh, a decline of 15% compared to the previous year. For the same year it recorded a net loss of ₹8.21 Lakh (net margin -98.4%) and EBITDA of -₹8.15 Lakh (EBITDA margin -97.7%). Revenue has declined at a compounded annual rate (CAGR) of 17% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Zaxilin Pharma Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered AddressH.No.1 – 5 – 209 New Maruthi Nagar Kothapet, Hyderabad, Telangana, India – 500035
- IndustryFood And Beverages, Manufacturing, Artificial Fibres
To see the full contact details of Zaxilin Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Zaxilin Pharma is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Zaxilin Pharma Private Limited, buy the company report.
Financials of Zaxilin Pharma Private Limited
FY 2023 filings availableZaxilin Pharma Private Limited reported revenue of ₹8.34 Lakh (down 15% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 17% over three years, including a 15% fall in the latest year. EBITDA fell 84% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹8.15 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹8.21 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -97.7% | ||||
| Net Profit Margin | -98.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Zaxilin Pharma Private Limited, buy the company report.
Board of directors of Zaxilin Pharma Private Limited
Zaxilin Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rama Devi Kolasani Also directs: Suprabhatam Townships Private Limited | Director | 25 Oct 2017 | 9 Years 0 Months | Current |
| Kolasani Srinivasa Rao Also directs: Suprabhatam Townships Private Limited | Director | 07 Jul 2022 | 4 Years 3 Months | Current |
Peer comparison
Zaxilin Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aidant Equipments Private Limited | ₹8.35 Lakh (FY 2020) | -26.0% | Bhadrak, Odisha, India | |||
| Eminent Auto Horizon Private Limited | ₹8.35 Lakh (FY 2024) | -40.0% | Hisar, Haryana, India | |||
| Jabbok Impex Private Limited | ₹8.35 Lakh (FY 2021) | -84.0% | Chengannur, Kerala, India | |||
| Rudani & Rudani Private Limited | ₹8.35 Lakh (FY 2025) | -90.0% | Kolkata, West Bengal, India | |||
| E3 Clothing and Accessories Private Limited | ₹8.34 Lakh (FY 2021) | -90.0% | Siliguri, West Bengal, India | |||
| Zaxilin Pharma Private Limitedthis company | ₹8.34 Lakh (FY 2023) | -₹8.21 Lakh | -98.4% | -15.0% | Hyderabad, Telangana, India | |
| Unj Import Private Limited | ₹8.34 Lakh (FY 2019) | -90.0% | New Delhi, Delhi, India | |||
| Kampson Life Sciences (India) Private Limited | ₹8.34 Lakh (FY 2024) | -21.0% | New Delhi, Delhi, India | |||
| Anantpushp Megamart Private Limited | ₹8.34 Lakh (FY 2025) | 53.0% | Patna, Bihar, India | |||
| Ram Prakash Sales & Services (P) Ltd | ₹8.34 Lakh (FY 2024) | 21.0% | Nagpur, Maharashtra, India | |||
| Deepak Good Health Private Limited | ₹8.34 Lakh (FY 2022) | Ghaziabad, Uttar Pradesh, India |
To see the full peer comparison of Zaxilin Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Zaxilin Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Zaxilin Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Zaxilin Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AABCZ1390A1ZM | Telangana | Active | 11 Jun 2018 |
To see the full GST registrations and return filing status of Zaxilin Pharma Private Limited, buy the company report.
Recent activity
Zaxilin Pharma Private Limited has 4 board changes on record since 2017: 3 appointments and 1 cessation. The latest: Kolasani Srinivasa Rao was appointed as Director on 07 Jul 2022.
Frequently asked questions
Zaxilin Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in manufacturing, within the food and beverages industry. It was incorporated on 25 October 2017 (9+ years old) and is registered under CIN U24304TG2017PTC120243.
Zaxilin Pharma has 2 current directors:
- Rama Devi Kolasani - Director
- Kolasani Srinivasa Rao - Director
The latest financial statements of Zaxilin Pharma on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Zaxilin Pharma is 36AABCZ1390A1ZM, registered in Telangana.
The CIN (Corporate Identification Number) of Zaxilin Pharma is U24304TG2017PTC120243. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zaxilin Pharma was incorporated on 25 October 2017, making it 9+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Zaxilin Pharma by revenue are Aidant Equipments Private Limited, Eminent Auto Horizon Private Limited, Jabbok Impex Private Limited, Rudani & Rudani Private Limited, E3 Clothing and Accessories Private Limited and 5 more, all in the same principal business activity (retail trading).
Kolasani Srinivasa Rao was appointed as Director on 07 Jul 2022. Sudhakararao Boyapati ceased to be Director on 07 Jul 2022. Rama Devi Kolasani was appointed as Director on 25 Oct 2017. Zaxilin Pharma has 4 board changes on record in total.
The registered office of Zaxilin Pharma is at H.No.1 – 5 – 209 New Maruthi Nagar Kothapet, Hyderabad, Telangana, India – 500035.
Zaxilin Pharma operates in the food and beverages industry, in the manufacturing segment.
The compliance status of Zaxilin Pharma is compliant as of 30 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
